An 8-year-old girl with a history of renal anomaly was referred to our hospital for evaluation of other organ deformities. The patient had lived in an orphanage since birth. Family and prenatal histories were not confirmed. She had undergone open-heart surgery due to a ventricular septal defect at the age of 6 months at another hospital. The patient was frequently treated for recurrent urinary tract infections. At the age of 4 years, she underwent an operation due to a diagnosis of vesicoureteral reflux (VUR) and a single dysplastic kidney in the pelvis.
On admission, the vital signs were as follows: systolic and diastolic blood pressure 118 (95th percentile) and 65 mmHg (75th–95th percentile); pulse rate 70 times/min.; respiratory rate 20 times/min.; body temperature 36.2℃. Body weight was 13.3 kg (-5.42 standard deviation score [SDS]) and height was 91.2 cm (-7.91 SDS). Physical examination revealed facial asymmetry, a short neck, external ear aplasia on the right side (
Fig. 1), and right thumb hypoplasia. She had normal female external genitalia and showed normal intellectual development. Initial blood examination results were as follows: hemoglobin, 10.7 g/dL; leukocyte, 8,020/μL; platelet count, 355×10
3/mm; serum total protein, 8.7 g/dL; serum albumin, 4.7 g/dL; total cholesterol, 246 mg/dL; aspartate aminotransferase, 38 IU/L; alanine aminotransferase, 21 IU/L; serum sodium, 141 mEq/L; potassium, 4.9 mEq/L; chloride-, 109 mEq/L. The blood urea nitrogen (BUN) and serum creatinine were 31.9 mg/dL and 1.40 mg/dL, respectively, and the glomerular filtration rate (by calculated Schwartz formula) was 35.8 mL/min/1.73 m
2. The urinalysis showed normal findings. The karyotype was normal female as 46, XX. The serum insulin-like growth factor 1 level was within the normal range as 186.0 ng/mL (normal range, 100–446 ng/mL).
A growth hormone (GH) stimulation test was performed to evaluate her extremely short stature. In the levodopa provocative test, the GH levels showed an exaggerated increase from 3.98 ng/dL to 46.5 ng/dL compared to the GH deficiency. The spine X-ray showed a fusion of C2–3, and C4–5 vertebrae as well as a fusion of L1–2, and L3–4 vertebrae. The costal X-ray showed that the 1st and 2nd ribs on both sides were fused. The X-ray also showed scoliosis and sacrococcygeal agenesis (
Fig. 2). Abdominal computed tomography revealed a single left dysplastic kidney, located in the pelvis, and uterine aplasia (
Fig. 3). Evaluation of the auditory system revealed sensorineural hearing loss of the right ear as well as external ear malformation. Based on the co-occurrence of all deformities, the patient was diagnosed with MURCS association. She was estimated to have chronic kidney disease (CKD) stage 3b, and she underwent a suprapubic cystostomy with a Foley catheter insertion to maintain a residual renal function. The patient started dietary intervention and conservative management, including oral medications of sulfonate calcium, cholecalciferol, and sodium bicarbonate. She started wearing a hearing aid and received psychiatric counseling. At the age of 12, the patient's medical condition was maintained, and height was 107.9 cm (-6.04 SDS) and weight 17.5 kg (-5.47 SDS). On physical examination, she showed the beginnings of secondary sexual characteristics such as thelarche (Tanner stage B2). The serum BUN and creatinine were 34.0 mg/dL and 1.73 mg/dL, respectively, and the glomerular filtration rate (Schwartz formula) was maintained as 34.3 mL/min/1.73 m
2. At the age of 18, her height was 132.6 cm (-5.78 SDS), her weight was 29.9 kg (-6.29 SDS), and blood pressure was 118 (50th–75th percentile)/75 mmHg (50th–75th percentile), and her pubertal development was complete, excluding menarche. Laboratory test results to evaluate her primary amenorrhea were as follows: LH was 16.0 mIU/mL (normal range, 0.5–7.6 mIU/mL), FSH was 2.43 mIU/mL (normal range, 1.2–13.4 mIU/mL), estradiol was 58.01 pg/mL (normal range, 54–242 pg/mL), dehydroepiandrosterone-sulfate was 80.3 μg/dL (normal range, 66–255 μg/dL), and the anti-Müllerian hormone was 3.43 ng/mL (normal range, 2.0–6.8 ng/mL). The renal functions had gradually declined; serum BUN and creatinine were 62.9 mg/dL and 5.05 mg/dL, respectively, and the glomerular filtration rate (Schwartz formula) was 14.4 mL/min/1.73 m
2. She was scheduled to undergo continuous ambulatory peritoneal dialysis due to CKD stage 5 (end-stage renal disease) (
Fig. 4). Since the procedure, she has been on peritoneal dialysis and receives conservative treatment as a renal replacement therapy.